← Back to all trials
Recruiting
NCT07335341
Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System
Conditions: Venous Embolism of Lower Extremities (Diagnosis), Arterial Embolism and Thrombosis, Acute DVT of Lower Extremity, Chronic DVT of Lower Extremity, DVT, Deep Vein Thrombosis Leg, Thrombus in the Peripheral Venous Vasculature, Peripheral Arterial Disease, Acute Limb Ischemia, Lower Extremity Acute Limb Ischemia, LE ALI
Sex: All
Ages: 22 Years – N/A
Healthy volunteers: No
Enrollment: 50
Sponsor: Medtronic Endovascular
Location: MedStar Health Washington D.C. District of Columbia
Summary
The purpose of Case-Specific Health Care Professional (HCP) Clinical Survey of Liberant™ Thrombectomy System, also known as the Liberant Clinical Assessment, is to collect first-in-human clinical data to confirm the safety and performance of the Medtronic Liberant™ thrombectomy system when used for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems
Eligibility Criteria
Patient case selection to be included in the clinical assessment will be specific to Liberant and will be made according to the following criteria:
1. Patient treated is age ≥ 22 years at the time of procedure
2. Use of Liberant in accordance with the device labeling within 72 hours of index procedure
Source: ClinicalTrials.gov (NCT07335341). StuddyBuddy aggregates publicly available trial information.
